2020
DOI: 10.1016/j.drugpo.2020.102806
|View full text |Cite
|
Sign up to set email alerts
|

Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 2 publications
0
16
0
Order By: Relevance
“…In response to the COVID-19 pandemic, clinical guidance has been issued to support OAT via telemedicine in the United States ( SAMHSA, 2020 ) and Canada ( Bruneau et al, 2020 ). Longer prescription durations and increased allowance for take-home doses for people on OAT have also been announced in nations such as Australia ( DHHS, 2020 ), Ireland ( EMCDDA, 2020 ), and Iran ( Deilamizade & Moghanibashi-Mansourieh, 2020 ). The UK government has called for an increase to harm reduction service provision and reach wherever possible, despite staffing limitations ( PHE, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…In response to the COVID-19 pandemic, clinical guidance has been issued to support OAT via telemedicine in the United States ( SAMHSA, 2020 ) and Canada ( Bruneau et al, 2020 ). Longer prescription durations and increased allowance for take-home doses for people on OAT have also been announced in nations such as Australia ( DHHS, 2020 ), Ireland ( EMCDDA, 2020 ), and Iran ( Deilamizade & Moghanibashi-Mansourieh, 2020 ). The UK government has called for an increase to harm reduction service provision and reach wherever possible, despite staffing limitations ( PHE, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is also important to trace the direct health impacts of COVID-19 in relation to the health of people who use drugs ( Dietze and Peacock, 2020 , Vasylyeva et al, 2020 ). Difficulties in adhering to quarantine and physical distancing increase transmission risk of COVID-19 for some populations of people who use drugs ( Arcadepani et al, 2020 , Deilamizade and Moghanibashi-Mansourieh, 2020 , Dietze and Peacock, 2020 , Vasylyeva et al, 2020 ). For instance, Arcadepani et al (2020) highlight the challenges of COVID-19 prevention in public and open-air drug scenes, focusing on a case study in São Paulo, Brazil.…”
Section: Introductionmentioning
confidence: 99%
“…A particular challenge is delivering COVID-19 prevention and quarantine services to homeless populations ( Banerjee and Bhattacharya, 2020 , Lenhard, 2020 , Marcus et al, 2020 ), particularly in settings where outbreaks have been observed ( Baggett et al, 2020 , Imbert et al, 2020 , Mosites et al, 2020 , Tobolowsky et al, 2020 ). This special issue highlights some of the specific challenges in providing COVID-19 prevention services among homeless people who use drugs in Iran ( Deilamizade & Moghanibashi-Mansourieh, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Some intervention, harm reduction, and recovery services have faced significant challenges in transitioning from in-person contact to online and phone support ( 9 ). Some have increased the amount of allowable unsupervised take-home opioid replacement therapy to facilitate social distancing measures, whilst others have flooded the market with Take Home Naloxone (THN) ( 7 , 10 , 11 ). Intensive experiences of isolation, known to be detrimental to well-being and recovery, have been exacerbated by the pandemic, with disastrous effects on the mental and physical health of many people who use drugs ( 12 ).…”
Section: Introductionmentioning
confidence: 99%